Protalix BioTherapeutics, Inc. Nontrade Receivables, Current
Protalix BioTherapeutics, Inc. (PLX) had Nontrade Receivables, Current of $26.00 thousand as of 2019-12-31, per its 10-K filed 2021-03-30.
Discontinued › Balance Sheet › Assets › Assets, Current
us-gaap:NontradeReceivablesCurrent · last filed 2021-03-30
- 2019-12-31: Nontrade Receivables, Current $26.00K.
| Period end | Nontrade Receivables, Current |
|---|---|
| 2019-12-31 | $26.00K 10-K · filed 2021-03-30 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| ANAVEX LIFE SCIENCES CORP. (AVXL) | United States | $0.218B | -18.37 |
| Alector, Inc. (ALEC) | United States | $0.213B | -1.90 |
| Compass Therapeutics, Inc. (CMPX) | United States | $0.204B | -5.35 |
| Aligos Therapeutics, Inc. (ALGS) | United States | $0.238B | -0.47 |
| Lineage Cell Therapeutics, Inc. (LCTX) | United States | $0.241B | -10.35 |
| Protara Therapeutics, Inc. (TARA) | United States | $0.198B | -3.22 |
| Alpha Cognition Inc. (ACOG) | $0.185B | -6.77 | |
| Coherus Oncology, Inc. (CHRS) | United States | $0.182B | -1.63 |
| SUTRO BIOPHARMA, INC. (STRO) | United States | $0.260B | -3.05 |
| PRECISION BIOSCIENCES INC (DTIL) | United States | $0.175B | -3.95 |